Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based neuroscience company Cortex Pharmaceuticals has reported a net loss of $3.13 million, or $0.07 per share, for the fourth quarter ended December 31, 2008, compared to a net loss of $3.27 million, or $0.07 per share, for the corresponding prior-year period.
Subscribe to our email newsletter
The reported losses included non-cash stock-based compensation charges for the quarters ended December 31, 2008 and 2007 of approximately $236,000 and $533,000, respectively.
For the fiscal year ended December 31, 2008, Cortex reported a net loss of $14.59 million, or $0.31 per share, compared to a net loss of $12.97 million, or $0.31 per share, for the previous year. These losses included non-cash stock-based compensation charges for the years ended December 31, 2008 and 2007 of approximately $1.3 million and $2.24 million, respectively.